Despite effective antiretroviral medications, milder
forms of HIV-associated neurocognitive disorders (HAND)
remain prevalent. The apolipoprotein-E(
APOE
)-
4
gene was inconsistently found to increase the risk for
HAND. Whether HIV subjects with
APOE
)-
4
allele(s) would show greater neuroinflammation, which
may contribute to cognitive deficits, is unknown and was
evaluated. 177 participants (97 seronegative controls
and 80 HIV subjects) were evaluated with
1
H
MRS, cognitive assessments and genotyping for
APOE
.
HIV subjects showed elevated levels of myoinositol
regardless of
APOE
-
4
genotype and across the agespan, which was associated
with poorer cognitive function.
APOE
-
4
combined with
1
H
MRS may be useful markers to predict HAND.